Stem cells in gastric cancer

World Journal of Gastroenterology

Volumn 21, Issue 1, 2015, Pages 112-123

  Zhao, Yue ^a   Feng, Fei ^a   Zhou, Yong Ning ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Cancer stem cells; CD133; CD44; E cadherin; Gastric cancer; Lgr5; Sox2; Troy; Villin

Indexed keywords

CD133 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOTOXIC ANTIBODY; G PROTEIN COUPLED RECEPTOR; HERMES ANTIGEN; KRUPPEL LIKE FACTOR 4; PACLITAXEL; PROTEIN LGR5; RETINOIC ACID; RETINOIC ACID DERIVATIVE; TAMOXIFEN; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; UVOMORULIN; VILLIN; WNT PROTEIN; CADHERIN; CDH1 PROTEIN, HUMAN; TUMOR MARKER;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER GROWTH; CANCER STEM CELL; CANCER TISSUE; CARCINOGENICITY; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL TRANSFORMATION; CLONAL EVOLUTION; COLONY FORMING UNIT; EPITHELIAL MESENCHYMAL TRANSITION; GASTRIC CANCER CELL LINE; GENE MUTATION; GERMLINE MUTATION; HELICOBACTER INFECTION; HEMATOPOIETIC STEM CELL; HUMAN; LOSS OF FUNCTION MUTATION; METASTASIS POTENTIAL; MOUSE MODEL; MULTIPOTENT STEM CELL; NONHUMAN; NUMERICAL CHROMOSOME ABERRATION; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR VOLUME; WNT SIGNALING PATHWAY; X CHROMOSOME INACTIVATION; ANIMAL; CELL SURVIVAL; COMPLICATION; GENETICS; HELICOBACTER PYLORI; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHENOTYPE; RISK FACTOR; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

ANIMALS; BIOMARKERS, TUMOR; CADHERINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL-MESENCHYMAL TRANSITION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MULTIPOTENT STEM CELLS; NEOPLASTIC STEM CELLS; PHENOTYPE; RISK FACTORS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84920917700     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i1.112     Document Type: Article

References (132)

1. Marx J . Medicine. Bone marrow cells: the source of gastric cancer? Science 2004; 306: 1455-1457 [PMID: 15567822 DOI: 10.1126/science.306.5701.1455a]
2. Houghton J, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 2005; 128 : 1567-1578 [PMID: 15887152 DOI: 10.1053/j.gastro.2005.03.037]
3. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29 [PMID: 10449602 DOI: 10.1002/(sici)1097-0215(19990924)83::1<18::aid-ijc5>3.3.co;2-d]
4. Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol 2013; 107 : 230-236 [PMID: 23129495 DOI: 10.1002/jso.23262]
5. Lauren P . The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49 [PMID: 14320675]
6. Hohenberger P, Gretschel S. Gastric cancer. Lancet 2003; 362: 305-315 [PMID: 12892963]
7. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132-1136 [PMID: 1891021 DOI: 10.1056/NEJM199110173251604]
8. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-1131 [PMID: 1891020 DOI: 10.1056/NEJM199110173251603]
9. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007; 133 : 659-672 [PMID: 17681184 DOI: 10.1053/j.gastro.2007.06.026]
10. Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194: 23-28 [PMID: 959840]
11. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-737 [PMID: 9212098 DOI: 10.1038/Nm0797-730]
12. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-648 [PMID: 7509044 DOI: 10.1038/367645a0]
13. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100 : 3983-3988 [PMID: 12629218 DOI: 10.1073/pnas.0530291100]
14. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401 [PMID: 15549107 DOI: 10.1038/nature03128]
15. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65: 10946-10951 [PMID: 16322242 DOI: 10.1158/0008-5472.CAN-05-2018]
16. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005; 65 : 9328-9337 [PMID: 16230395 DOI: 10.1158/0008-5472.CAN-05-1343]
17. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445 : 106-110 [PMID: 17122772 DOI: 10.1038/nature05372]
18. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115 [PMID: 17122771 DOI: 10.1038/nature05384]
19. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, Clarke MF. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007; 104: 10158-10163 [PMID: 17548814 DOI: 10.1073/pnas.0703478104]
20. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007; 132: 2542-2556 [PMID: 17570225 DOI: 10.1053/ j.gastro.2007.04.025]
21. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67: 1030-1037 [PMID: 17283135 DOI: 10.1158/0008-5472.CAN-06-2030]
22. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1: 313-323 [PMID: 18371365 DOI: 10.1016/j.stem.2007.06.002]
23. Prince ME, Ailles LE. Cancer stem cells in head and neck squamous cell cancer. J Clin Oncol 2008; 26: 2871-2875 [PMID: 18539966 DOI: 10.1200/JCO.2007.15.1613]
24. Beck B, Blanpain C. Unravelling cancer stem cell potential. Nat Rev Cancer 2013; 13 : 727-738 [PMID: 24060864 DOI: 10.1038/nrc3597]
25. Pang R, Law WL, Chu AC, Poon JT, Lam CS, Chow AK, Ng L, Cheung LW, Lan XR, Lan HY, Tan VP, Yau TC, Poon RT, Wong BC. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 2010; 6: 603-615 [PMID: 20569697 DOI: 10.1016/ j.stem.2010.04.001]
26. Allan AL, Vantyghem SA, Tuck AB, Chambers AF. Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis. Breast Dis 2006; 26: 87-98 [PMID: 17473368]
27. Li L, Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science 2010; 327: 542-545 [PMID: 20110496 DOI: 10.1126/science.1180794]
28. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756-760 [PMID: 17051156 DOI: 10.1038/nature05236]
29. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, Clarke MF. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009; 458: 780-783 [PMID: 19194462 DOI: 10.1038/nature07733]
30. Moitra K, Lou H, Dean M. Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development. Clin Pharmacol Ther 2011; 89: 491-502 [PMID: 21368752 DOI: 10.1038/clpt.2011.14]
31. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G, Medema JP, Stassi G. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007; 1 : 389-402 [PMID: 18371377 DOI: 10.1016/j.stem.2007.08.001]
32. Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, Rimm DL, Wong H, Rodriguez A, Herschkowitz JI, Fan C, Zhang X, He X, Pavlick A, Gutierrez MC, Renshaw L, Larionov AA, Faratian D, Hilsenbeck SG, Perou CM, Lewis MT, Rosen JM, Chang JC. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 2009; 106 : 13820-13825 [PMID: 19666588 DOI: 10.1073/ pnas.0905718106]
33. Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, Parada LF. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012; 488: 522-526 [PMID: 22854781 DOI: 10.1038/nature11287]
34. Karam SM, Leblond CP. Identifying and counting epithelial cell types in the "corpus" of the mouse stomach. Anat Rec 1992; 232 : 231-246 [PMID: 1546802 DOI: 10.1002/ar.1092320208]
35. Karam SM, Leblond CP. Dynamics of epithelial cells in the corpus of the mouse stomach. I. Identification of proliferative cell types and pinpointing of the stem cell. Anat Rec 1993; 236: 259-279 [PMID: 8338232 DOI: 10.1002/ar.1092360202]
36. Karam SM, Leblond CP. Dynamics of epithelial cells in the corpus of the mouse stomach. II. Outward migration of pit cells. Anat Rec 1993; 236 : 280-296 [PMID: 8338233 DOI: 10.1002/ar.1092360203]
37. Karam SM, Leblond CP. Dynamics of epithelial cells in the corpus of the mouse stomach. III. Inward migration of neck cells followed by progressive transformation into zymogenic cells. Anat Rec 1993; 236 : 297-313 [PMID: 8338234 DOI: 10.1002/ar.1092360204]
38. Karam SM, Leblond CP. Dynamics of epithelial cells in the corpus of the mouse stomach. V. Behavior of enteroendocrine and caveolated cells: general conclusions on cell kinetics in the oxyntic epithelium. Anat Rec 1993; 236: 333-340 [PMID: 8338236 DOI: 10.1002/ar.1092360206]
39. Karam SM. Dynamics of epithelial cells in the corpus of the mouse stomach. IV. Bidirectional migration of parietal cells ending in their gradual degeneration and loss. Anat Rec 1993; 236: 314-332 [PMID: 8338235 DOI: 10.1002/ar.1092360205]
40. Karam SM, Straiton T, Hassan WM, Leblond CP. Defining epithelial cell progenitors in the human oxyntic mucosa. Stem Cells 2003; 21: 322-336 [PMID: 12743327 DOI: 10.1634/ stemcells.21-3-322]
41. Bjerknes M, Cheng H. Multipotential stem cells in adult mouse gastric epithelium. Am J Physiol Gastrointest Liver Physiol 2002; 283: G767-G777 [PMID: 12181193 DOI: 10.1152/ ajpgi.00415.2001]
42. Nomura S, Kaminishi M, Sugiyama K, Oohara T, Esumi H. Clonal analysis of isolated single fundic and pyloric gland of stomach using X-linked polymorphism. Biochem Biophys Res Commun 1996; 226 : 385-390 [PMID: 8806644 DOI: 10.1006/ bbrc.1996.1365]
43. Nomura S, Esumi H, Job C, Tan SS. Lineage and clonal development of gastric glands. Dev Biol 1998; 204: 124-135 [PMID: 9851847 DOI: 10.1006/dbio.1998.9055]
44. Braunstein EM, Qiao XT, Madison B, Pinson K, Dunbar L, Gumucio DL. Villin: A marker for development of the epithelial pyloric border. Dev Dyn 2002; 224: 90-102 [PMID: 11984877 DOI: 10.1002/dvdy.10091]
45. Qiao XT, Ziel JW, McKimpson W, Madison BB, Todisco A, Merchant JL, Samuelson LC, Gumucio DL. Prospective identification of a multilineage progenitor in murine stomach epithelium. Gastroenterology 2007; 133 : 1989-1998 [PMID: 18054570 DOI: 10.1053/j.gastro.2007.09.031]
46. Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH, Sato T, Stange DE, Begthel H, van den Born M, Danenberg E, van den Brink S, Korving J, Abo A, Peters PJ, Wright N, Poulsom R, Clevers H. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 2010; 6: 25-36 [PMID: 20085740 DOI: 10.1016/j.stem.2009.11.013]
47. Stange DE, Koo BK, Huch M, Sibbel G, Basak O, Lyubimova A, Kujala P, Bartfeld S, Koster J, Geahlen JH, Peters PJ, van Es JH, van de Wetering M, Mills JC, Clevers H. Differentiated Troy+ chief cells act as reserve stem cells to generate all lineages of the stomach epithelium. Cell 2013; 155: 357-368 [PMID: 24120136 DOI: 10.1016/j.cell.2013.09.008]
48. Hashimoto T, Schlessinger D, Cui CY. Troy binding to lymphotoxin-alpha activates NF kappa B mediated transcription. Cell Cycle 2008; 7: 106-111 [PMID: 18202551]
49. Que J, Okubo T, Goldenring JR, Nam KT, Kurotani R, Morrisey EE, Taranova O, Pevny LH, Hogan BL. Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm. Development 2007; 134 : 2521-2531 [PMID: 17522155 DOI: 10.1242/ dev.003855]
50. Arnold K, Sarkar A, Yram MA, Polo JM, Bronson R, Sengupta S, Seandel M, Geijsen N, Hochedlinger K. Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell 2011; 9: 317-329 [PMID: 21982232 DOI: 10.1016/j.stem.2011.09.001]
51. Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, Bayazitov IT, Poppleton H, Zakharenko S, Ellison DW, Gilbertson RJ. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009; 457: 603-607 [PMID: 19092805 DOI: 10.1038/nature07589]
52. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ, Clevers H. Crypt stem cells as the cells-oforigin of intestinal cancer. Nature 2009; 457: 608-611 [PMID: 19092804 DOI: 10.1038/nature07602]
53. Cozzio A, Passegué E, Ayton PM, Karsunky H, Cleary ML, Weissman IL. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 2003; 17: 3029-3035 [PMID: 14701873 DOI: 10.1101/gad.1143403]
54. Odze RD. Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective. Am J Gastroenterol 2005; 100 : 1853-1867 [PMID: 16144130 DOI: 10.1111/ j.1572-0241.2005.50096.x]
55. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676 [PMID: 16904174 DOI: 10.1016/j.cell.2006.07.024]
56. Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JC, Wu TT, Huang S, Xie K. Drastic down-regulation of Krüppellike factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 2005; 65: 2746-2754 [PMID: 15805274]
57. Katz JP, Perreault N, Goldstein BG, Actman L, McNally SR, Silberg DG, Furth EE, Kaestner KH. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology 2005; 128 : 935-945 [PMID: 15825076 DOI: 10.1053/ j.gastro.2005.02.022]
58. Li Q, Jia Z, Wang L, Kong X, Li Q, Guo K, Tan D, Le X, Wei D, Huang S, Mishra L, Xie K. Disruption of Klf4 in villinpositive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice. Gastroenterology 2012; 142 : 531-542 [PMID: 22155367 DOI: 10.1053/ j.gastro.2011.11.034]
59. Wei D, Kanai M, Jia Z, Le X, Xie K. Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res 2008; 68: 4631-4639 [PMID: 18559508 DOI: 10.1158/0008-5472.CAN-07-5953]
60. Yoon HS, Chen X, Yang VW. Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage. J Biol Chem 2003; 278: 2101-2105 [PMID: 12427745 DOI: 10.1074/jbc.M211027200]
61. Tetreault MP, Yang Y, Travis J, Yu QC, Klein-Szanto A, Tobias JW, Katz JP. Esophageal squamous cell dysplasia and delayed differentiation with deletion of krüppel-like factor 4 in murine esophagus. Gastroenterology 2010; 139: 171-81.e9 [PMID: 20347813 DOI: 10.1053/j.gastro.2010.03.048]
62. Nakatsuru S, Yanagisawa A, Ichii S, Tahara E, Kato Y, Nakamura Y, Horii A. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet 1992; 1: 559-563 [PMID: 1338691 DOI: 10.1093/ Hmg/1.8.559]
63. Kakiuchi M, Nishizawa T, Ueda H, Gotoh K, Tanaka A, Hayashi A, Yamamoto S, Tatsuno K, Katoh H, Watanabe Y, Ichimura T, Ushiku T, Funahashi S, Tateishi K, Wada I, Shimizu N, Nomura S, Koike K, Seto Y, Fukayama M, Aburatani H, Ishikawa S. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma. Nat Genet 2014; 46 : 583-587 [PMID: 24816255 DOI: 10.1038/ ng.2984]
64. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-170 [PMID: 8861899]
65. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA, Dove WF. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992; 256: 668-670 [PMID: 1350108]
66. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR, Wang TC. Gastric cancer originating from bone marrow-derived cells. Science 2004; 306 : 1568-1571 [PMID: 15567866 DOI: 10.1126/ science.1099513]
67. Mizrak D, Brittan M, Alison M. CD133: molecule of the moment. J Pathol 2008; 214 : 3-9 [PMID: 18067118 DOI: 10.1002/path.2283]
68. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, Buck DW. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 5002-5012 [PMID: 9389720]
69. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, Bray RA, Waller EK, Buck DW. A novel fivetransmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997; 90: 5013-5021 [PMID: 9389721]
70. Corti S, Nizzardo M, Nardini M, Donadoni C, Locatelli F, Papadimitriou D, Salani S, Del Bo R, Ghezzi S, Strazzer S, Bresolin N, Comi GP. Isolation and characterization of murine neural stem/progenitor cells based on Prominin-1 expression. Exp Neurol 2007; 205 : 547-562 [PMID: 17466977 DOI: 10.1016/j.expneurol.2007.03.021]
71. Olempska M, Eisenach PA, Ammerpohl O, Ungefroren H, Fandrich F, Kalthoff H. Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Int 2007; 6: 92-97 [PMID: 17287174]
72. Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T, Moriwaki H. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 2006; 351 : 820-824 [PMID: 17097610 DOI: 10.1016/j.bbrc.2006.10.128]
73. Wu C, Xie Y, Gao F, Wang Y, Guo Y, Tian H, Li Y, Fan W. Lgr5 expression as stem cell marker in human gastric gland and its relatedness with other putative cancer stem cell markers. Gene 2013; 525: 18-25 [PMID: 23664892 DOI: 10.1016/j.gene.2013.04.067]
74. Zhao P, Li Y, Lu Y. Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma. BMC Cancer 2010; 10: 218 [PMID: 20487522 DOI: 10.1186/1471-2407-10-218]
75. Hashimoto K, Aoyagi K, Isobe T, Kouhuji K, Shirouzu K. Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer. Gastric Cancer 2014; 17 : 97-106 [PMID: 23558457 DOI: 10.1007/s10120-013-0255-9]
76. Wen L, Chen XZ, Yang K, Chen ZX, Zhang B, Chen JP, Zhou ZG, Mo XM, Hu JK. Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review. PLoS One 2013; 8 : e59154 [PMID: 23533603 DOI: 10.1371/journal.pone.0059154]
77. Gallatin WM, Weissman IL, Butcher EC. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 1983; 304: 30-34 [PMID: 6866086]
78. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-1313 [PMID: 1694723]
79. Almond A. Hyaluronan. Cell Mol Life Sci 2007; 64: 1591-1596 [PMID: 17502996 DOI: 10.1007/s00018-007-7032-z]
80. Stamenkovic I, Amiot M, Pesando JM, Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989; 56: 1057-1062 [PMID: 2466575]
81. Goldstein LA, Zhou DF, Picker LJ, Minty CN, Bargatze RF, Ding JF, Butcher EC. A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 1989; 56: 1063-1072 [PMID: 2466576]
82. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89: 12160-12164 [PMID: 1465456]
83. Idzerda RL, Carter WG, Nottenburg C, Wayner EA, Gallatin WM, St John T. Isolation and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium. Proc Natl Acad Sci USA 1989; 86 : 4659-4663 [PMID: 2471974]
84. Ruiz P, Schwärzler C, Günthert U. CD44 isoforms during differentiation and development. Bioessays 1995; 17: 17-24 [PMID: 7535522 DOI: 10.1002/bies.950170106]
85. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24 [PMID: 1707342]
86. Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, Lau CK, Li ML, Tam KH, Lam CT, Poon RT, Fan ST. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 2008; 47: 919-928 [PMID: 18275073 DOI: 10.1002/ hep.22082]
87. Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, Clevers H, Pals ST. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 1999; 154 : 515-523 [PMID: 10027409 DOI: 10.1016/ S0002-9440(10)65297-2]
88. Hao J, Chen H, Madigan MC, Cozzi PJ, Beretov J, Xiao W, Delprado WJ, Russell PJ, Li Y. Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression. Br J Cancer 2010; 103: 1008-1018 [PMID: 20736947 DOI: 10.1038/sj.bjc.6605839]
89. Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, Masuko T, Shimizu T, Ishikawa T, Kai K, Takahashi E, Imamura Y, Baba Y, Ohmura M, Suematsu M, Baba H, Saya H. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 2011; 19: 387-400 [PMID: 21397861 DOI: 10.1016/ j.ccr.2011.01.038]
90. Ghaffarzadehgan K, Jafarzadeh M, Raziee HR, Sima HR, Esmaili-Shandiz E, Hosseinnezhad H, Taghizadeh-Kermani A, Moaven O, Bahrani M. Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance. World J Gastroenterol 2008; 14: 6376-6381 [PMID: 19009655 DOI: 10.3748/wjg.14.6376]
91. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009; 27: 1006-1020 [PMID: 19415765 DOI: 10.1002/stem.30]
92. da Cunha CB, Oliveira C, Wen X, Gomes B, Sousa S, Suriano G, Grellier M, Huntsman DG, Carneiro F, Granja PL, Seruca R. De novo expression of CD44 variants in sporadic and hereditary gastric cancer. Lab Invest 2010; 90 : 1604-1614 [PMID: 20856229 DOI: 10.1038/labinvest.2010.155]
93. Lau WM, Teng E, Chong HS, Lopez KA, Tay AY, Salto-Tellez M, Shabbir A, So JB, Chan SL. CD44v8-10 is a cancerspecific marker for gastric cancer stem cells. Cancer Res 2014; 74: 2630-2641 [PMID: 24618343 DOI: 10.1158/0008-5472.CAN-13-2309]
94. Hirata K, Suzuki H, Imaeda H, Matsuzaki J, Tsugawa H, Nagano O, Asakura K, Saya H, Hibi T. CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence. Br J Cancer 2013; 109: 379-386 [PMID: 23778530 DOI: 10.1038/bjc.2013.314]
95. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 2003; 300: 1430-1434 [PMID: 12775840 DOI: 10.1126/science.1081919]
96. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelialmesenchymal transitions in development and disease. Cell 2009; 139 : 871-890 [PMID: 19945376 DOI: 10.1016/ j.cell.2009.11.007]
97. Bessède E, Staedel C, Acuña Amador LA, Nguyen PH, Chambonnier L, Hatakeyama M, Belleannée G, Mégraud F, Varon C. Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transitionlike changes. Oncogene 2014; 33: 4123-4131 [PMID: 24096479 DOI: 10.1038/onc.2013.380]
98. Giannakis M, Chen SL, Karam SM, Engstrand L, Gordon JI. Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proc Natl Acad Sci USA 2008; 105: 4358-4363 [PMID: 18332421 DOI: 10.1073/pnas.0800668105]
99. Wang K, Kan J, Yuen ST, Shi ST, Chu KM, Law S, Chan TL, Kan Z, Chan AS, Tsui WY, Lee SP, Ho SL, Chan AK, Cheng GH, Roberts PC, Rejto PA, Gibson NW, Pocalyko DJ, Mao M, Xu J, Leung SY. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet 2011; 43: 1219-1223 [PMID: 22037554 DOI: 10.1038/ ng.982]
100. Zang ZJ, Cutcutache I, Poon SL, Zhang SL, McPherson JR, Tao J, Rajasegaran V, Heng HL, Deng N, Gan A, Lim KH, Ong CK, Huang D, Chin SY, Tan IB, Ng CC, Yu W, Wu Y, Lee M, Wu J, Poh D, Wan WK, Rha SY, So J, Salto-Tellez M, Yeoh KG, Wong WK, Zhu YJ, Futreal PA, Pang B, Ruan Y, Hillmer AM, Bertrand D, Nagarajan N, Rozen S, Teh BT, Tan P. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet 2012; 44 : 570-574 [PMID: 22484628 DOI: 10.1038/ng.2246]
101. McLachlan RW, Yap AS. Not so simple: the complexity of phosphotyrosine signaling at cadherin adhesive contacts. J Mol Med (Berl) 2007; 85 : 545-554 [PMID: 17429596 DOI: 10.1007/s00109-007-0198-x]
102. Leckband D, Prakasam A. Mechanism and dynamics of cadherin adhesion. Annu Rev Biomed Eng 2006; 8: 259-287 [PMID: 16834557 DOI: 10.1146/annurev. bioeng.8.061505.095753]
103. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Höfler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54: 3845-3852 [PMID: 8033105]
104. Oda T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W, Sugimura T, Hirohashi S. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 1994; 91: 1858-1862 [PMID: 8127895]
105. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392 : 402-405 [PMID: 9537325 DOI: 10.1038/32918]
106. Shinmura K, Kohno T, Takahashi M, Sasaki A, Ochiai A, Guilford P, Hunter A, Reeve AE, Sugimura H, Yamaguchi N, Yokota J. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis 1999; 20 : 1127-1131 [PMID: 10357799]
107. Yoon KA, Ku JL, Yang HK, Kim WH, Park SY, Park JG. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J Hum Genet 1999; 44: 177-180 [PMID: 10319582 DOI: 10.1007/s100380050137]
108. Gayther SA, Gorringe KL, Ramus SJ, Huntsman D, Roviello F, Grehan N, Machado JC, Pinto E, Seruca R, Halling K, MacLeod P, Powell SM, Jackson CE, Ponder BA, Caldas C. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 1998; 58: 4086-4089 [PMID: 9751616]
109. Barber M, Murrell A, Ito Y, Maia AT, Hyland S, Oliveira C, Save V, Carneiro F, Paterson AL, Grehan N, Dwerryhouse S, Lao-Sirieix P, Caldas C, Fitzgerald RC. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J Pathol 2008; 216 : 295-306 [PMID: 18788075 DOI: 10.1002/path.2426]
110. Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 2000; 26: 16-17 [PMID: 10973239 DOI: 10.1038/79120]
111. Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simöes M. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 2001; 20: 1525-1528 [PMID: 11313896 DOI: 10.1038/sj.onc.1204234]
112. Oliveira C, de Bruin J, Nabais S, Ligtenberg M, Moutinho C, Nagengast FM, Seruca R, van Krieken H, Carneiro F. Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour. Oncogene 2004; 23: 2236-2240 [PMID: 14661064 DOI: 10.1038/sj.onc.1207335]
113. Becker KF, Höfler H. Frequent somatic allelic inactivation of the E-cadherin gene in gastric carcinomas. J Natl Cancer Inst 1995; 87 : 1082-1084 [PMID: 7616601 DOI: 10.1093/ jnci/87.14.1082]
114. Corso G, Roviello F, Paredes J, Pedrazzani C, Novais M, Correia J, Marrelli D, Cirnes L, Seruca R, Oliveira C, Suriano G. Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management. Eur J Surg Oncol 2007; 33: 1061-1067 [PMID: 17434710 DOI: 10.1016/j.ejso.2007.03.001]
115. Chan AO, Lam SK, Chu KM, Lam CM, Kwok E, Leung SY, Yuen ST, Law SY, Hui WM, Lai KC, Wong CY, Hu HC, Lai CL, Wong J. Soluble E-cadherin is a valid prognostic marker in gastric carcinoma. Gut 2001; 48: 808-811 [PMID: 11358900 DOI: 10.1136/Gut.48.6.808]
116. Ciruna B, Rossant J. FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev Cell 2001; 1: 37-49 [PMID: 11703922 DOI: 10.1016/S1534-5807(01)00017-X]
117. Caca K, Kolligs FT, Ji X, Hayes M, Qian J, Yahanda A, Rimm DL, Costa J, Fearon ER. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/ lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Differ 1999; 10: 369-376 [PMID: 10392898]
118. Herzig M, Savarese F, Novatchkova M, Semb H, Christofori G. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling. Oncogene 2007; 26: 2290-2298 [PMID: 17043652 DOI: 10.1038/ sj.onc.1210029]
119. Hoschuetzky H, Aberle H, Kemler R. Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol 1994; 127: 1375-1380 [PMID: 7962096]
120. Fedor-Chaiken M, Hein PW, Stewart JC, Brackenbury R, Kinch MS. E-cadherin binding modulates EGF receptor activation. Cell Commun Adhes 2003; 10 : 105-118 [PMID: 14681060]
121. Qian X, Karpova T, Sheppard AM, McNally J, Lowy DR. E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J 2004; 23 : 1739-1748 [PMID: 15057284 DOI: 10.1038/ sj.emboj.7600136]
122. Perrais M, Chen X, Perez-Moreno M, Gumbiner BM. E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions. Mol Biol Cell 2007; 18 : 2013-2025 [PMID: 17392517 DOI: 10.1091/mbc.E06-04-0348]
123. Zhang L, Yang J, Cai J, Song X, Deng J, Huang X, Chen D, Yang M, Wery JP, Li S, Wu A, Li Z, Li Z, Liu Y, Chen Y, Li Q, Ji J. A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy. Sci Rep 2013; 3: 2992 [PMID: 24141978 DOI: 10.1038/srep02992]
124. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715 [PMID: 18485877 DOI: 10.1016/j.cell.2008.03.027]
125. Morel AP, Lièvre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008; 3: e2888 [PMID: 18682804 DOI: 10.1371/journal.pone.0002888]
126. Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer KE, Ahmadi R, Lohr J, Dictus C, Gdynia G, Combs SE, Goidts V, Helmke BM, Eckstein V, Roth W, Beckhove P, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende C. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res 2010; 16: 2715-2728 [PMID: 20442299 DOI: 10.1158/1078-0432.CCR-09-1800]
127. Karsy M, Albert L, Tobias ME, Murali R, Jhanwar-Uniyal M. All-trans retinoic acid modulates cancer stem cells of glioblastoma multiforme in an MAPK-dependent manner. Anticancer Res 2010; 30: 4915-4920 [PMID: 21187470]
128. Ying M, Wang S, Sang Y, Sun P, Lal B, Goodwin CR, Guerrero-Cazares H, Quinones-Hinojosa A, Laterra J, Xia S. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. Oncogene 2011; 30: 3454-3467 [PMID: 21383690 DOI: 10.1038/onc.2011.58]
129. Ginestier C, Wicinski J, Cervera N, Monville F, Finetti P, Bertucci F, Wicha MS, Birnbaum D, Charafe-Jauffret E. Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle 2009; 8: 3297-3302 [PMID: 19806016]
130. Rappa G, Fodstad O, Lorico A. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 2008; 26 : 3008-3017 [PMID: 18802032 DOI: 10.1634/stemcells.2008-0601]
131. Smith LM, Nesterova A, Ryan MC, Duniho S, Jonas M, Anderson M, Zabinski RF, Sutherland MK, Gerber HP, Van Orden KL, Moore PA, Ruben SM, Carter PJ. CD133/ prominin-1 is a potential therapeutic target for antibodydrug conjugates in hepatocellular and gastric cancers. Br J Cancer 2008; 99 : 100-109 [PMID: 18542072 DOI: 10.1038/ sj.bjc.6604437]
132. Jin C, Yang Z, Yang J, Li H, He Y, An J, Bai L, Dou K. Paclitaxel-loaded nanoparticles decorated with anti-CD133 antibody: a targeted therapy for liver cancer stem cells. J Nanoparticle Res 2013; 16 : 2157 [DOI: 10.1007/ s11051-013-2157-5]